A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease
Clinical trial NCT02207829 · COMPLETED
Trial details
- NCT number
- NCT02207829
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-05-25
- Enrollment
- 1017
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.